Aviva plc

Aviva plc

AIVAF
Aviva plcUS flagOther OTC
8.76
USD
- -
- -
26.20BMarket Cap
Aviva plc
AIVAF
(Other OTC)

Recent

price

8.76

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
14.32
10.4
14.61
11.44
14.43
6.21
13.25
11.95
4.53
16.81
7.69
8.38
-6.25
14.06
13.79
20.12
Revenue per Share
0.49
0.1
-1.06
0.67
0.52
0.24
0.17
0.36
0.39
0.64
0.7
0.5
-0.34
0.37
0.23
0.36
Basic EPS, GAAP
0.53
-0.19
1.11
1.32
-0.26
1.21
1.11
1.85
1.31
1.45
-0.79
-0.75
5.05
-1.07
2.86
-0.96
Free Cash Flow per Basic Share
0.17
0.16
0.22
0.15
0.16
0.17
0.22
0.24
0.29
0.3
0.06
0.29
0.27
0.31
0.32
0.44
Dividend per Share
2.08
2.32
0.72
1.04
1.8
1.53
1.43
1.45
1.37
1.53
2.13
1.46
-0.45
1.09
0.78
0.78
Book Value per Share
3.86
3.65
2.91
2.78
3.27
2.74
2.89
3.33
3.29
3.49
4.06
3.49
2.23
2.2
1.63
1.61
Tangible Book Value per Share
2,938
2,879
2,945
2,975
2,978
3,786
4,100
4,089
4,011
3,958
3,972
3,936
3,126
2,878
2,894
2,855
Basic Weighted Avg Shares
42,063
29,953
43,021
34,052
42,986
23,517
54,323
48,869
18,166
66,546
30,556
32,986
-19,538
40,456
39,904
57,436
Sales/Revenue/Turnover
6.74
- -
-5.69
8.84
6.2
4.98
- -
6.26
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
218
191
163
141
127
414
435
427
432
476
396
333
199
185
192
238
Depreciation Expense
1,463
297
-3,102
2,008
1,569
936
703
1,497
1,568
2,548
2,798
1,966
-1,051
1,085
683
1,033
Net Income, GAAP
24.71
24.54
149.14
31.46
26.35
22.36
28
17.82
20.76
21.08
17.13
39.57
- -
23.25
29.29
26.81
Effective Tax Rate (%)
3.48
0.99
-7.21
5.9
3.65
3.98
1.29
3.06
8.63
3.83
9.16
5.96
5.38
2.68
1.71
1.8
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
14,949
7,944
8,179
7,263
6,862
8,285
9,653
10,286
9,169
9,373
10,109
7,344
6,889
6,695
5,908
5,986
LT Debt
17,725
15,363
11,360
11,017
12,276
18,270
19,551
19,135
18,455
18,685
20,560
16,690
10,214
9,600
8,621
11,089
Total Equity
6.62
- -
5.29
10.25
9.85
3.78
- -
7.84
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
6.28
4.36
-23.07
16.95
12.66
7.6
5.44
9.67
10.47
16.45
16.04
12.37
- -
15.08
9.09
13.14
Return on Capital (%)
28.26
4.38
-70.85
76.44
36.79
16.5
11.79
25.15
27.17
43.85
38.37
27.48
- -
- -
24.68
45.5
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.26%
-9.04%
28.63%
Free Cash Flow
-136.91%
-251.68%
-133.29%
Net Income, GAAP
-20.72%
-74.45%
51.24%
Sales/Revenue/Turnover
-14.54%
-83.15%
43.94%
Total Cash Common Dividend
37.98%
78.04%
34.31%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
40,456
2024
- -
- -
- -
- -
39,904
2025
- -
- -
- -
- -
57,436

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.37
2024
- -
- -
- -
- -
0.23
2025
- -
- -
- -
- -
0.36

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.31
2024
- -
- -
- -
- -
0.32
2025
- -
- -
- -
- -
0.44
Business
Aviva plc is a leading British multinational insurance company that provides general insurance, life insurance, long-term savings products, pensions, retirement solutions, protection, health insurance, and fund management services through its principal subsidiaries including Aviva Insurance for general insurance (encompassing personal lines such as motor, home, and travel under brands like Quotemehappy, and commercial lines), Aviva Investors for asset management with £253 billion in assets under management, Aviva Canada as the second-largest general insurer in Canada, and operations in Wealth & Retirement covering platforms, workplace pensions, bulk purchase annuities, individual annuities, equity release, and health products; the company serves approximately 25.2 million customers primarily in the United Kingdom, Ireland, and Canada, with additional presence in China through Aviva-Cofco and in India through Aviva India. Headquartered in London, England, Aviva traces its origins to 1696 through heritage entities like the Hand in Hand Fire & Life Insurance Society and was formally established as CGNU plc in 2000 from the merger of Norwich Union and CGU plc, adopting the Aviva name in 2002. In recent developments, Aviva completed its £3.7 billion acquisition of Direct Line Group on 1 July 2025, integrating leading UK personal lines brands and expecting £225 million in cost synergies by 2028 (up from initial estimates) plus over £500 million in capital synergies, while advancing integration to boost capital-light earnings toward over 75% of the business by 2028; earlier, it acquired AIG Life Limited in September 2023 for £460 million and Optiom in Canada in November 2023 for £100 million, formed a multi-year partnership with NFU Mutual for rural insurance distribution in 2025, and continues strong growth with Q3 2025 general insurance premiums up 12% to £10 billion and wealth net flows of £8.3 billion.

Company News

APIChatGPT
  • UK's Aviva takes full ownership of India unit after New Delhi eases foreign investment rules

  • Aviva detects record £230m in bogus insurance claims as use of AI rises

  • Berenberg initiates on Aviva with 'buy' rating, sees 36% total return

  • Aviva's pension profits are under pressure, but RBC still sees upside

  • Legal & General and Standard Life investors loved Aviva's mixed results

  • Aviva premiums jump 19% but bulk annuity sales fall

  • Aviva Posts Rise in Insurance Premiums

  • Aviva: Strong Results And Capital Returns Support Continued Upside

  • Could Aviva hand investors a 30% return in the next 12 months? This bank thinks so

  • Aviva shares: why three banks think the FTSE 100 insurer is still too cheap

  • Aviva plc (AVVIY) Q4 2025 Earnings Call Transcript

  • Aviva hikes dividend 10% and unveils £350m buyback as 2026 targets delivered early

  • Aviva: Strategy May Continue To Deliver Strong Results (Rating Downgrade)

  • Aviva set to resume buybacks as full-year results approach

  • Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys

  • Aviva exposed as motor insurers face new AI de-rating, Barclays warns

  • Aviva presents "attractive' entry point for investors - broker

  • Aviva is transformed and is a 'buy' says broker

  • Aviva preferred over L&G as broker reviews life insurers

  • Aviva Bio Announces FDA Guidance on Development Pathway for Women's Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291